Barclays
GBIM

Barclays’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Barclays’s Portfolio GBIM Stock Details GBIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,304
Closed -$20K – 7837
2014
Q3 		$20K Buy
+3,304
New +$33.8K ﹤0.01% 6500

Other funds holding GBIM

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $2.93B AUM 4.27% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barclays's GBIM Position: Q4 2014 in Review

Barclays sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q4 2014, closing a stake of 3,304 shares — an estimated $20K sold.

Barclays first reported a position in GBIM in Q3 2014 and held it in 1 quarter. The position peaked at $20K in Q3 2014. 16 funds tracked by Wall St. Rank hold GBIM as of Q4 2014.

  • Barclays reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Barclays sold 3,304 GLOBEIMMUNE INC COM STK (DE) shares in Q4 2014, an estimated $20K.
  • Barclays first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q3 2014 and held it in 1 quarter.
  • Barclays's GLOBEIMMUNE INC COM STK (DE) position peaked at $20K in Q3 2014.
  • 16 funds tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q4 2014.

Based on Barclays's 13F filing for Q4 2014, filed 13 Feb 2015.